Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.

Ugale V, Sharon N, Salunkhe C, Salunkhe J, Lokwani D, Patil K, Reddy PN, Kulkarni P

Open source

DOI
10.1002/ddr.70338
Published
2026 Aug
Container
Drug development research
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1002/ddr.70338,
  title = {Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.},
  author = {Ugale V and Sharon N and Salunkhe C and Salunkhe J and Lokwani D and Patil K and Reddy PN and Kulkarni P},
  year = {2026},
  journal = {Drug development research},
  doi = {10.1002/ddr.70338},
  url = {https://doi.org/10.1002/ddr.70338}
}

RIS

TY  - JOUR
TI  - Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.
AU  - Ugale V
AU  - Sharon N
AU  - Salunkhe C
AU  - Salunkhe J
AU  - Lokwani D
AU  - Patil K
AU  - Reddy PN
AU  - Kulkarni P
PY  - 2026
JO  - Drug development research
DO  - 10.1002/ddr.70338
UR  - https://doi.org/10.1002/ddr.70338
ER  - 

APA

V, U., N, S., C, S., J, S., D, L., K, P., PN, R., & P, K. (2026). Naphthalene-4H-Chromene Molecular Hybrids as Dual Cholinesterase Inhibitors for the Treatment of Alzheimer's Disease.. Drug development research. https://doi.org/10.1002/ddr.70338

Source records